NextPlat Corp, a global consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide, announced that its ClearMetrx subsidiary has commenced late-stage development of ClearMetrX 4.0. This next-generation healthcare data analytics and reporting software features a full range of artificial intelligence (AI)-enhanced capabilities, with internal rollout expected in Q4 2025 and commercialization for new and existing customers in the first half of 2026.
ClearMetrX 4.0 integrates AI for enhanced healthcare data analytics.
Expected internal rollout in Q4 2025; commercialization in H1 2026.
Features revenue forecasting, predictive inventory, and fraud detection.
Targets physicians, MSOs, 340B entities, and pharmacies.
AI in healthcare market projected to grow from $26.57B in 2024 to $187.69B by 2030.
Builds on ClearMetrX's role in improving patient adherence and business outcomes.
ClearMetrX is a cloud-based, end-to-end reporting platform that streamlines data analytics for physicians, management services organizations (MSOs), 340B entities, and pharmacies, and is actively used across the Company's pharmacies and client network. ClearMetrX 4.0 will integrate an array of AI-powered enhancements into the software, designed to increase its value as a comprehensive decision-support system, enabling a more streamlined way to collect, analyze and operationalize organizational healthcare data. According to Grandview Research, the global AI in healthcare market size was estimated at USD 26.57 billion in 2024 and is projected to reach USD 187.69 billion by 2030, growing at a CAGR of 38.62% from 2025 to 2030. A key factor driving market growth is the increasing demand in the healthcare sector for enhanced efficiency, accuracy, and better patient outcomes.
Birute Norkute, Vice President of Healthcare Operations at NextPlat, said, "Since its introduction, ClearMetrX has demonstrated its capabilities to positively impact not only the business of healthcare for us and a growing list of customers, but importantly, support better outcomes through improved patient adherence. With ClearMetrX 4.0, we are honoring our commitment to harness the power of technology such as AI to further improve the efficiency and effectiveness of healthcare to the benefit of all stakeholders."
Highlighted features of ClearMetrX 4.0 include:
Revenue Forecasting: Utilizing AI/ML models to predict revenue, prescription volumes, and patient demand with accuracy.
Predictive Inventory Management: Intelligent AI forecasting to optimize stock levels and reduce shortages or waste.
Anomaly & Exception Detection: Real-time AI tools to spot abnormal prescribing, dispensing, or claims patterns.
Audit Assistance, Analytics & Reporting: AI-powered dashboards that automate evidence gathering, compliance reporting, and deliver actionable analytics.
Fraud Detection: Advanced AI analytics to identify suspicious billing or dispensing activity.
What-If Simulations: AI-driven scenario models to evaluate financial and compliance outcomes.
To learn more about ClearMetrX or to request information on how it can meet your needs or to schedule a demonstration, please visit https://www.clearmetrx.com/
NextPlat's development of ClearMetrX 4.0 positions the company to capitalize on the booming AI healthcare market, delivering tools that drive operational efficiency and superior patient care for its network of healthcare providers.
Nextplat is a global consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide. Through acquisitions, joint ventures, and collaborations, the Company seeks to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-Commerce presence and revenue. NextPlat currently operates an e-Commerce communications division offering voice, data, tracking, and IoT products and services worldwide as well as pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.